SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-025930
Filing Date
2023-02-07
Accepted
2023-02-06 21:31:43
Documents
8
Effectiveness Date
2023-02-07

Document Format Files

Seq Description Document Type Size
1 S-8 d429858ds8.htm S-8 54153
2 EX-5.1 d429858dex51.htm EX-5.1 7442
3 EX-23.1 d429858dex231.htm EX-23.1 1948
4 EX-99.1 d429858dex991.htm EX-99.1 111069
5 EX-99.2 d429858dex992.htm EX-99.2 30557
6 EX-99.3 d429858dex993.htm EX-99.3 49090
7 EX-FILING FEES d429858dexfilingfees.htm EX-FILING FEES 15144
8 GRAPHIC g429858g0206050809256.jpg GRAPHIC 2231
  Complete submission text file 0001193125-23-025930.txt   273665
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269611 | Film No.: 23592544
SIC: 2834 Pharmaceutical Preparations